Pediatric Transplant ID Workshop 2020

Need Statement

Infectious diseases (IDs) inflict a substantial risk to children before and after transplantation.
For example, IDs contracted after heart transplants constitute as the second-leading cause of death in children (1). Common IDs that occur after transplantation are bacterial, fungal, and viral infections (2). These can be acquired via the healthcare setting or through donor-recipient transmission
(3). Infections that occur during the first month are mostly bacterial infections; while infections between 1 to 6 months after the transplantation are mostly viral, such as the cytomegalovirus (CMV) and the Epstein-Barr virus (EBV) infections. After 6 months, infection with hepatitis B and C, CMV, EBV, or papilloma virus affect approximately 10% of patients (3). As the immune system of children differs from the one in adults (1), and IDs remain a significant issue for pediatric transplant patients. Specific knowledge and expertise is urgently needed in order to effectively prevent, diagnose, and treat pediatric transplant IDs (4).

In the past decades, new diagnoses, treatments, and preventive strategies have led to substantial improvement in the management of IDs and other complications occurring in pediatric organ
transplantation. Despite the considerable progress, there still is a gap of knowledge among many clinicians regarding the optimal diagnosis and treatment of IDs in pediatric transplant patients. Along with the added challenge for clinicians and researchers to stay on top of the latest advances and knowledge in the field.

With an increasing number of specialists focusing on pediatric transplant IDs in a field that continues to grow, there is a need for programs dedicated to building expertise among clinicians and providing education on the latest news in pediatric transplant IDs.

World's Leading Experts

​The Pediatric Transplant ID Workshop proudly collaborates with a large number of international experts in the field of pediatric transplant IDs. By working together with our extensive global network of experts from variousbackgrounds in the field, we can ensure to design and deliver the most relevant and state-of-the-art program.


 

 

References
1. Tsuda T., Dadlani G.H. and Pizzarro C. (2018) “Pediatric Heart Transplant in the United States: Current Status, Outcomes, and Ongoing Challenges.” Journal of Pediatric Cardiology and Cardiac Surgery
2. Green M. & Michaels M.G. (2012) Infections in Pediatric Solid Organ Transplant Recipients. Journal of the Pediatric Infectious Diseases Society
3. Allen U.D. (2013) “Minimizing infection risks after paediatric organ transplants: Advice for practitioners.” Paediatrics & Child Health
4. Danziger-Isakov L. et al. (2013) Recommended curriculum for training in pediatric transplant infectious diseases. Journal of the Pediatric Infectious
Diseases Society